Benign intracranial hypertension associated with the withdrawal of a non-ergot dopamine agonist
- Department of Endocrinology, Royal Liverpool Hospital, Liverpool, UK
- Division of Clinical Neurology, University Hospital, Queens Medical Centre, Nottingham, UK
Abstract
The cases are reported of two patients who developed benign intracranial hypertension after the withdrawal of the novel non-ergot derived dopamine agonist CV 205 502 (quinagolide).







